Highest-materiality recent filing
Change Agents (CHGA) issues $336,000 in OID notes and 100,000-share pre-funded warrants
On Sept. 30, 2026, Change Agents issued Second Tranche September 2026 OID Notes: $336,000 principal, $36,000 OID, $300,000 gross proceeds.
Change Agents issues $280K OID notes, amends Hudson equity line, grants warrants
Issued $280K aggregate OID notes (gross $250K; $30K discount) at 7% interest, maturing 4/8/2027; prepayable at 105%.
Change Agents issues $280K OID notes, amends Hudson equity line, issues pre-funded warrants
Issued $280,000 OID notes (gross $250k); proceeds repay $19,710 Vanquish note and $19,710 June 2025 notes.
Change Agents (CHGA) implements 1-for-20 reverse split to meet Nasdaq $1 bid requirement
Reverse split effective 4:01 p.m. ET Aug 28, 2026; split-adjusted trading starts Aug 31 on Nasdaq under CHGA.
Change Agents Corp. enters $825K loan, issues 360K shares to lender
Principal $825,000; net proceeds $254,350 after $41,250 admin fee and $529,400 prior loan repayment.
Change Agents Corp enters $10M equity purchase agreement with Hudson Global Ventures
Entered Equity Purchase Agreement with Hudson Global Ventures for up to $10,000,000 of common stock.
Name change to Change Agents Corporation effective July 20, 2026; no stockholder vote required.
Avalon GloboCare issues $500K in notes (18.75% OID); appoints Sam Knipper CFO, Luisa Ingargiola CSO
Issued $250K note to Dune Equity Holdings ($200K gross) and $250K note to FirstFire Global Opportunities ($200K gross), each with $50K original issue discount.
Avalon GloboCare files pro forma financials for sale of real estate unit to Chairman for $9M
Sale of Avalon RT 9 Properties to Chairman Wenzhao Lu for $9M; excess proceeds ~$2M recorded to additional paid-in capital.
Avalon GloboCare receives Nasdaq notice of non-compliance with minimum bid price rule
Nasdaq notified Avalon GloboCare on April 15, 2026 of bid price deficiency per Listing Rule 5550(a)(2).
Avalon Globocare shareholders approve reverse stock split, note conversions, and Lu exchange
All 7 proposals passed at special meeting on March 30, 2026.
Avalon GloboCare corrects share count in $2.8M private placement
The amendment corrects the number of shares reported under Item 3.02 in the original March 2 filing.
Avalon GloboCare closes $3.25M private placement with up to $6.5M additional warrant proceeds
Issued 6,372,550 shares (or pre-funded warrants) at $0.51, plus Series A-1/A-2 warrants for 6,372,550 shares each at $0.51.
Avalon Globocare issues $233,910 convertible note; three directors resign, three appointed
Note principal $233,910 (incl. $26,910 OID); net proceeds $207,000; matures Feb 15, 2027.
Avalon GloboCare sells 100% of property subsidiary to Chairman for $9M, relieved of $5.9M mortgage
Sold 100% membership interests in Avalon RT 9 Properties, LLC to Chairman Wenzhao Lu for $9M total consideration.
Avalon GloboCare converts $2.6M of debentures to common stock, slashes debt
Converted $2.6M principal from June 2024 institutional note into shares; $288K repaid in cash.
Avalon GloboCare renews FDA registration for KetoAir; plans Q2 2026 launch via Catch-Up AI platform
FDA registration renewed for KetoAir breathalyzer (Reg. No. 3026284320) for ketogenic health management.
Avalon GloboCare regains Nasdaq minimum equity compliance, launches generative AI video platform
Nasdaq confirmed compliance with minimum stockholders' equity rule 5550(b); previous hearing cancelled.
Acquired RPM Interactive, a generative AI SaaS platform for automated short-form video, via merger with subsidiary Avalon Quantum AI.
Avalon GloboCare receives Nasdaq delisting notice over equity deficiency
On Nov 19, 2025, Nasdaq notified Avalon GloboCare (ALBT) it is not in compliance with Listing Rule 5550(b) due to stockholders' equity of ($3,891,270) vs required $2.5M.
Avalon GloboCare reveals YOOV preliminary FY2025 revenue of $59.3M, net income $3.8M
YOOV's preliminary unaudited FY2025 (year ended March 31, 2025): revenue $59.3M, net income $3.8M (206% growth).
Sold 121,200 shares and pre-funded warrants for 354,300 shares at $475,500; net proceeds $450,500.
On October 7, 2026, Meng Li notified Change Agents Corporation (the “Company”) of her decision to resign from her position as the Company’s Interim Chief Executive Officer, Chief Operating Officer and Secretary, effective October 8, 2026.
On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).
On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).
Max materiality 0.90 · Median 0.53 · Most common event other_material